Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$226,653
-$82,469 QoQ
Shares Held
1,794
-19.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,843
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAX Financial Group, LLC holds $3,929,562 across 7 Drug Manufacturers - General names. GILD ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,103 | $1,322,971 | |
| 2 | NVO |
Novo Nordisk A S
|
13,437 | $644,169 | |
| 3 | JNJ |
Johnson & Johnson
|
2,114 | $536,892 | |
| 4 | ABBV |
AbbVie Inc.
|
2,019 | $508,061 | |
| 5 | AZN |
Astrazeneca PLC
|
2,504 | $474,808 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,794 | $226,653 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,653 | 1,794 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $309,122 | 2,218 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $340,235 | 2,772 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $318,126 | 2,866 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $348,353 | 3,142 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $443,045 | 3,954 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $475,058 | 5,143 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $679,104 | 8,100 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $582,636 | 8,492 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $558,970 | 7,631 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $632,445 | 7,807 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $628,821 | 8,391 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $646,848 | 8,393 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $755,773 | 9,109 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $779,603 | 9,081 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $765,326 | 12,406 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $761,561 | 12,321 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $698,061 | 11,742 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $704,534 | 9,703 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $676,846 | 9,690 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $658,990 | 9,570 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $586,775 | 9,079 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $497,423 | 8,538 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $443,088 | 7,012 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $410,859 | 5,340 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $374,323 | 5,007 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||